Structure of Baricitinib
CAS No.: 1187594-09-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Baricitinib (LY3009104; INCB028050) is a selective, orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
Synonyms: LY3009104; INCB028050
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1187594-09-7 |
Formula : | C16H17N7O2S |
M.W : | 371.42 |
SMILES Code : | N#CCC1(N2N=CC(C3=C4C(N=CN3)=NC=C4)=C2)CN(S(=O)(CC)=O)C1 |
Synonyms : |
LY3009104; INCB028050
|
MDL No. : | MFCD27920779 |
InChI Key : | XUZMWHLSFXCVMG-UHFFFAOYSA-N |
Pubchem ID : | 44205240 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
PBMCs | 5 nM | 24 h | Assess the effects of Baricitinib on PBMCs | PMC11732195 |
primary human monocytes | 0.001, 0.01, 0.1, 1.0, 10 μM | 2 h | To evaluate the effect of Baricitinib on HIV-induced monocyte activation, results showed Baricitinib significantly reduced activation markers. | PMC6764124 |
Calu-3 cells | 1 μM | 6 h | Baricitinib reduced poly I:C-induced CXCL10 gene expression to a similar extent as 5 μM apabetalone. | PMC9946890 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mouse | Mouse model of Down syndrome | Oral | 10 mg/kg | Once a day, throughout the experiment | Baricitinib treatment rescued lethal immune responses and cytokine induction in Dp16 mice. | PMC7727402 |
Mice | Down syndrome model | Oral | 10 mg/kg | Once daily for 17 days | Baricitinib treatment attenuates global dysregulation of gene expression across multiple organ systems in a mouse model of Down syndrome, particularly in inflammatory-related gene expression. | PMC10306300 |
Mice | Primary biliary cholangitis (PBC) model | Oral gavage | 10 mg/kg | Once daily for two weeks | After baricitinib treatment, liver inflammation was alleviated, liver-resident Th1-like cells were reduced, serum IgM-AMA levels were significantly decreased, and bile duct damage was relieved. | PMC11458754 |
SCID mice | HIV-associated neurocognitive disorder model | subcutaneous injection | 10 mg/kg and 50 mg/kg | once daily for 7 days | To evaluate the effect of Baricitinib on behavioral abnormalities and neuroinflammation in HIV-associated neurocognitive disorders, results showed Baricitinib significantly improved cognitive function and reduced neuroinflammation. | PMC6764124 |
Mice | vFLIP-chimera mouse model | Intraperitoneal injection | 10 mg/kg | Every 2 days, for a total of 9 treatments | Baricitinib alleviated inflammatory pathology and immune dysfunction in vFLIP mice by inhibiting the STAT3 signaling pathway, reducing weight loss and systemic lymphopenia, and decreasing the plasma concentration of multiple pro-inflammatory cytokines. | PMC8435761 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03440892 | - | Recruiting | January 2020 | Sweden ... More >> Dept of Rheumatology and Inflammation research Recruiting Gothenburg, Sweden Contact: Sofia T Silfverswärd sofia.silfversward@rheuma.gu.se Less << | |
NCT01185353 | Arthritis, Rheumatoid | Phase 2 | Completed | - | - |
NCT01398475 | Chronic Inflammatory Disorder|... More >>Arthritis, Rheumatoid Less << | PHASE1 | COMPLETED | 2025-09-11 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, 117597, Singapore Less << |
NCT00902486 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT01710358 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01185353 | - | Completed | - | - | |
NCT01398475 | Chronic Inflammatory Disorder|... More >>Arthritis, Rheumatoid Less << | PHASE1 | COMPLETED | 2025-09-11 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, 117597, Singapore Less << |
NCT01721057 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01710358 | - | Completed | - | - | |
NCT01469013 | Arthritis, Rheumatoid | Phase 2 | Completed | - | Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 260-8712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 730-0017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 063-0811 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 673-1462 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaragi, Japan, 316-0035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 890-0067 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 252-0392 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 857-1165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oita, Japan, 870-0823 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8607 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 586-8521 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 130-0013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 933-0874 Less << |
NCT01724580 | Chronic Atypical Neutrophilic ... More >>Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE)|Juvenile Dermatomyositis (JDM)|Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)|Aicardi-Goutières Syndrome (AGS) Less << | APPROVED_FOR_MARKETING | - | Translational Autoinflammatory... More >> Disease (TADS), Bethesda, Maryland, 20892, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Great Ormond Street Hospital, London, WC1N 1EH, United Kingdom Less << | |
NCT00902486 | - | Completed | - | - | |
NCT01711359 | - | Completed | - | - | |
NCT01721057 | - | Completed | - | - | |
NCT01711359 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01247350 | Healthy Volunteer | Phase 1 | Completed | - | United States, Hawaii ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Honolulu, Hawaii, United States Less << |
NCT01247350 | - | Completed | - | - | |
NCT01469013 | - | Completed | - | - | |
NCT01885078 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | March 22, 2024 | - |
NCT03755466 | Rheumatoid Arthritis | Phase 2 | Recruiting | November 20, 2023 | Japan ... More >> Yukio Nakamura Recruiting Matsumoto, Nagano, Japan, 3908621 Contact: Yukio Nakamura, MD, PhD +81-263-37-2659 yxn14@aol.jp Principal Investigator: Yukio Nakamura, MD, PhD Less << |
NCT01536951 | - | Completed | - | - | |
NCT01536951 | Healthy Participants | Phase 1 | Completed | - | United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 Less << |
NCT01683409 | Diabetic Kidney Disease | Phase 2 | Completed | - | - |
NCT01299285 | Healthy Volunteers | PHASE1 | COMPLETED | 2025-03-11 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States Less << |
NCT01721044 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03428100 | Atopic Dermatitis | Phase 3 | Recruiting | March 1, 2021 | - |
NCT02576938 | Atopic Dermatitis | Phase 2 | Completed | - | United States, California ... More >> Dermatology Research Associates Los Angeles, California, United States, 90045 United States, Florida Forward Clinical Trials, Inc Tampa, Florida, United States, 33624 United States, Georgia Medical Dermatology Specialists Atlanta, Georgia, United States, 30342 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New York Icahn School of Medicine New York, New York, United States, 10029 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Texas Menter Dermatology Research Institute Dallas, Texas, United States, 75246 Center for Clinical Studies Houston, Texas, United States, 77004 Center for Clinical Studies Houston, Texas, United States, 77065 Center for Clinical Studies Webster, Texas, United States, 77598 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka-shi, Japan, 815-0082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sapporo, Japan, 060-0063 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Takaoka-shi, Japan, 933-0871 Less << |
NCT02576938 | - | Completed | - | - | |
NCT03334435 | Atopic Dermatitis | Phase 3 | Recruiting | August 27, 2021 | - |
NCT01683409 | - | Completed | - | - | |
NCT01299285 | Healthy Volunteers | PHASE1 | COMPLETED | 2025-03-11 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States Less << |
NCT03733301 | Atopic Dermatitis | Phase 3 | Recruiting | August 28, 2019 | - |
NCT01960140 | - | Completed | - | - | |
NCT01960140 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT01490632 | Psoriasis Ski... More >>n Diseases Skin Diseases, Papulosquamous Less << | Phase 2 | Completed | - | - |
NCT01721044 | - | Completed | - | - | |
NCT02265705 | Rheumatoid Arthritis | Phase 3 | Completed | - | Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1015ABO For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1431FWO For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1440AAD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rosario, Argentina, S2000CFJ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Argentina, J5402DIL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Miguel De Tucuman, Argentina, T4000AXL Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 04266-010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01244-030 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100044 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jinan, China, 250012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ningbo, China, 315010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pingxiang, China, 337055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shantou, China, 515041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wuhan City, China, 430030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yancheng, China, 224005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. ZhuZhou, China, 412007 Less << |
NCT01924299 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT03334396 | Atopic Dermatitis | Phase 3 | Recruiting | August 15, 2019 | - |
NCT01859078 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT01490632 | - | Completed | - | - | |
NCT01924299 | - | Completed | - | - | |
NCT03742973 | Primary Biliary Cholangitis | Phase 2 | Not yet recruiting | October 15, 2020 | United States, California ... More >> Southern California GI and Liver Centers (SCLC) Not yet recruiting Coronado, California, United States, 92118 Contact 619-522-0399 Principal Investigator: Tarek Hassanein Cedars-Sinai Comprehensive Transplant Center Not yet recruiting Los Angeles, California, United States, 90048 Contact 310-423-6000 Principal Investigator: Vinay Sundaram UC Davis Transplant Research Not yet recruiting Sacramento, California, United States, 95816 Contact 916-734-0779 Principal Investigator: Christopher Bowlus United States, Colorado University of Colorado School of Medicine Not yet recruiting Aurora, Colorado, United States, 80045 Contact 728-848-2292 Principal Investigator: Lisa Forman United States, Florida Florida Digestive Health Specialists Not yet recruiting Lakewood Ranch, Florida, United States, 34211 Contact 941-727-7772 Principal Investigator: Guy W Neff Schiff Center for Liver Diseases/University of Miami Not yet recruiting Miami, Florida, United States, 33136 Contact 305-243-4615 Principal Investigator: Cynthia Levy United States, Louisiana Tulane University School of Medicine Not yet recruiting New Orleans, Louisiana, United States, 70112 Contact 504-988-5344 Principal Investigator: Fredric Regenstein United States, Maryland The Institute for Digestive Health and Liver Disease at Mercy Not yet recruiting Baltimore, Maryland, United States, 21202 Contact 410-332-9356 Principal Investigator: Paul Thuluvath United States, Michigan Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact 313-916-9465 Principal Investigator: Stuart Gordon United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact 507-284-3917 Principal Investigator: John Eaton United States, Missouri St Louis University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63104 Contact 314-577-8764 Principal Investigator: Bruce Bacon United States, Ohio UH Cleveland Medical Center Not yet recruiting Cleveland, Ohio, United States, 44106 Contact 216-844-5387 Principal Investigator: Anthony Post United States, Texas Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact 713-798-1966 Principal Investigator: John Vierling Italy Azienda Ospedaliera San Gerardo Not yet recruiting Monza, Milano, Italy, 20052 Contact 390392333673 Principal Investigator: Pietro Invernizzi Istituto Clinico Humanitas Not yet recruiting Rozzano, Milano, Italy, 20089 Contact 390282244556 Principal Investigator: Ana Lleo De Nalda Azienda Ospedaliera Umberto I Not yet recruiting Ancona, Italy, 60124 Contact 390715963377 Principal Investigator: Marco Marzioni Puerto Rico Klinical Investigations Group, LLC Not yet recruiting San Juan, Puerto Rico, 00909 Contact 7879197865 Principal Investigator: Federico Rodriguez University of Puerto Rico, Medical Sciences Campus Not yet recruiting San Juan, Puerto Rico, 00936 Contact 7877540101 Principal Investigator: Esther A. Torres Less << |
NCT01896726 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT03334422 | Atopic Dermatitis | Phase 3 | Active, not recruiting | January 9, 2019 | - |
NCT01896726 | - | Completed | - | - | |
NCT01937026 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT01937026 | - | Completed | - | - | |
NCT01859078 | - | Completed | - | - | |
NCT03570749 | Alopecia Areata | Phase 2 Phase 3 | Recruiting | March 25, 2022 | - |
NCT02708095 | - | Completed | - | - | |
NCT03616912 | Systemic Lupus Erythematosus | Phase 3 | Recruiting | February 16, 2021 | - |
NCT02708095 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT03616964 | Systemic Lupus Erythematosus | Phase 3 | Recruiting | February 16, 2021 | - |
NCT02263911 | Healthy Participants | PHASE1 | COMPLETED | 2025-12-14 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hachioji, Tokyo, 192-0071, Japan Less << |
NCT03435081 | Atopic Dermatitis | Phase 3 | Recruiting | March 25, 2021 | - |
NCT01910311 | - | Completed | - | - | |
NCT02759731 | Chronic Graft vs Host Disease|... More >>Chronic Graft-Versus-Host Disease Less << | PHASE1|PHASE2 | COMPLETED | 2024-05-30 | National Institutes of Health ... More >>Clinical Center, Bethesda, Maryland, 20892, United States Less << |
NCT01925144 | - | Completed | - | - | |
NCT01925144 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT01910311 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT03773978 | Juvenile Idiopathic Arthritis | Phase 3 | Not yet recruiting | September 18, 2021 | Brazil ... More >> LMK Serviços Médicos S/S Not yet recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90540-000 Contact 555130613440 Principal Investigator: Maria Mercedes Caracciolo Picarelli Hospital de Clinicas de Porto Alegre Not yet recruiting Porto Alegre, RS, Brazil, 90035-903 Contact 555133597662 Principal Investigator: Claiton Viegas Brenol Faculdade de Medicina de Botucatu Not yet recruiting Botucatu, Sao Paulo, Brazil, 18618-970 Contact 551438801663 Principal Investigator: Claudia Saad Magalhães Faculdade de Ciências Médicas - UNICAMP Not yet recruiting Campinas, Sao Paulo, Brazil, 13083-887 Contact 551935219421 Principal Investigator: Simone Appenzeller Universidade Federal de São Paulo - Escola Paulista de Medicina Not yet recruiting São Paulo, Brazil, 04038-001 Contact 551155747627 Principal Investigator: Maria Teresa Terreri Germany Universitätsklinikum Heidelberg Not yet recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact 496221564823 Principal Investigator: Thomas Lutz Universitätsklinikum Tübingen Not yet recruiting Tübingen, Baden-Württemberg, Germany, 72076 Contact 4970712980901 Principal Investigator: Jasmin Kümmerle-Deschner Asklepios Klinik Sankt Augustin GmbH Not yet recruiting Saint Augustin, Nordrhein-Westfalen, Germany, 53757 Contact 492149249201 Principal Investigator: Gerd Horneff HELIOS Klinikum Berlin-Buch Not yet recruiting Berlin, Germany, 13125 Contact 4930940114510 Principal Investigator: Ralf Trauzeddel Charité Universitätsmedizin Berlin Not yet recruiting Berlin, Germany, 13353 Contact 4930450566528 Principal Investigator: Kirsten Minden Hamburger Zentrum für Kinder und Jugendrheumatologie Not yet recruiting Hamburg, Germany, 22081 Contact 494020923694 Principal Investigator: Ivan Foeldvari Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan, 920 8641 Contact 81120360605 Principal Investigator: Masaki Shimizu Kanagawa Prefectural Childrens Medical Center Not yet recruiting Yokohama, Kanagawa, Japan, 232-0066 Contact 81120360605 Principal Investigator: Tomoyuki Imagawa Yokohama City University Hospital Not yet recruiting Yokohama, Kanagawa, Japan, 236-0004 Contact 81120360605 Principal Investigator: Shuichi Ito Miyagi Children's Hospital Recruiting Sendai-shi, Miyagi, Japan, 989 3126 Contact 81120360605 Principal Investigator: Yoshihiro Umebayashi Osaka Medical College Hospital Not yet recruiting Takatsuki, Osaka, Japan, 569-8686 Contact 81120360605 Principal Investigator: Kosuke Syabana Saitama Children's Medical Center Not yet recruiting Saitama-shi, Saitama, Japan, 330 8777 Contact 81120360605 Principal Investigator: Yutaka Kawano Tokyo Medical And Dental University Hospital Not yet recruiting Bunkyo-ku, Tokyo, Japan, 113-8519 Contact 81120360605 Principal Investigator: Masaaki Mori St. Lukes International Hospital Not yet recruiting Chuo-Ku, Tokyo, Japan, 104 8560 Contact 81120360605 Principal Investigator: Kenichi Yamaguchi Kagoshima University Hospital Not yet recruiting Kagoshima, Japan, 890-8520 Contact 81120360605 Principal Investigator: Yoshifumi Kawano Niigata University Medical & Dental Hospital Not yet recruiting Niigata, Japan, 951-8520 Contact 81120360605 Principal Investigator: Utako Kaneko Mexico CREA de Guadalajara, S.C. Not yet recruiting Guadalajara, Jalisco, Mexico, 44620 Contact 5233336483333 Principal Investigator: Gabriel Vega Cornejo Hospital Univ. "Dr. José Eleuterio González" Not yet recruiting Monterrey, Nuevo León, Mexico, 64460 Contact 83338623 Principal Investigator: Nadina Eugenia Rubio Perez Cemdeicy S.C.P. Not yet recruiting Merida, Yucatán, Mexico, 97130 Contact 529992863277 Principal Investigator: Efren Alberto Canul Novelo Investigación y Biomedicina de Chihuahua, SC Not yet recruiting Chihuahua, Mexico, 31000 Contact 526144373003 Principal Investigator: Cesar Pacheco Tena Instituto de Investigaciones Aplicadas a la Neurociencia A.C Not yet recruiting Durango, Mexico, 34000 Contact 526181963882 Principal Investigator: Edgar Hernandez Vargas Russian Federation V.A. Nasonova Research Institute of Rheumatology Not yet recruiting Moscow, Russian Federation, 115522 Contact 74996143965 Principal Investigator: Irina Nikishina Morozov Children's City Hospital Not yet recruiting Moscow, Russian Federation, 119049 Contact 74959598800 Principal Investigator: Saniya Valieva Center of Children`s Health Not yet recruiting Moscow, Russian Federation, 119991 Contact 84959671420 Principal Investigator: Ekaterina Alexeeva First Moscow State Medical University n.a. Sechenov Not yet recruiting Moscow, Russian Federation, 119991 Contact 84992480181 Principal Investigator: Elena Zholobova St. Petersburg State Pediatric Medical University Not yet recruiting Saint-Petersburg, Russian Federation, 194100 Contact 78122950646 Principal Investigator: Vyacheslav Chasnyk Less << |
NCT02758613 | - | Completed | - | - | |
NCT01968057 | - | Completed | - | - | |
NCT02263911 | Healthy Participants | PHASE1 | COMPLETED | 2025-12-14 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hachioji, Tokyo, 192-0071, Japan Less << |
NCT01870388 | Liver Diseases|Hepatic Insuffi... More >>ciency Less << | PHASE1 | COMPLETED | 2025-07-13 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami, Florida, 33014, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Orlando, Florida, 32806, United States Less << |
NCT01968057 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT01870388 | Liver Diseases|Hepatic Insuffi... More >>ciency Less << | PHASE1 | COMPLETED | 2025-07-13 | For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami, Florida, 33014, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Orlando, Florida, 32806, United States Less << |
NCT03026504 | Arteritis, Giant Cell | PHASE2 | COMPLETED | 2021-04-12 | Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less << |
NCT02758613 | Healthy | Phase 1 | Completed | - | China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Beijing, China, 100034 Less << |
NCT03212638 | Healthy | Phase 1 | Completed | - | Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less << |
NCT02340104 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1‐877‐CTLILLY Leeds, Yorkshire, United Kingdom, LS2 9LH Less << |
NCT03701789 | Rheumatoid Arthritis|Bone Dens... More >>ity|Finger Joints Less << | PHASE3 | UNKNOWN | 2021-10-11 | Universitiy Hospital Erlangen,... More >> Erlangen, Bavaria, 91052, Germany Less << |
NCT03773965 | Juvenile Idiopathic Arthritis | PHASE3 | RECRUITING | 2025-07-31 | Instituto CAICI SRL, Rosario, ... More >>Santa Fe, S2000, Argentina|Centro de Investigaciones Médicas Tucuman, SAN M. DE Tucuman, Tucumán, T4000AXL, Argentina|The Children's Hospital at Westmead, Westmead, New South Wales, 2145, Australia|Royal Children's Hospital, Melbourne, Victoria, 3052, Australia|Perth Children's Hospital, Perth, Western Australia, 6009, Australia|Landeskrankenhaus Bregenz, Bregenz, Vorarlberg, 6900, Austria|Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna, Wien, 1090, Austria|Cliniques universitaires Saint-Luc, Brussels, Bruxelles-Capitale, Région De, 1200, Belgium|UZ Gent, Gent, Oost-Vlaanderen, 9000, Belgium|UZ Leuven, Leuven, Vlaams-Brabant, 3000, Belgium|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Faculdade de Medicina da UNESP, Botucatu, S?o Paulo, 18618-686, Brazil|Instituto da Crianca do Hospital das Clinicas da FMUSP, Sao Paulo, S?o Paulo, 05403-000, Brazil|IPITEC, S?o Paulo, 01221-020, Brazil|Universidade Federal de Sao Paulo, S?o Paulo, 04024-002, Brazil|Children's Hospital Capital Institute of Pediatrics, Beijing, Beijing, 100020, China|Beijing Children's hospital, Capital Medical University, Beijing, Beijing, 100045, China|Beijing Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|The Second Affiliated Hospital Chongqing Medical University, Chongqing, Chongqing, 400010, China|The Children's Hospital of Chongqing Medical University, Chongqing, Chongqing, 400065, China|Childrens Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210008, China|Children's Hospital of Soochow University, Suzhou, Jiangsu, 215025, China|Detska nemocnice FN Brno, Brno, Brno-město, 613 00, Czechia|Fakultni nemocnice Motol, Praha, Praha 5, 150 06, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 12808, Czechia|Rigshospitalet, Copenhagen, Hovedstaden, DK-2100, Denmark|Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland, 8200, Denmark|Centre Hospitalier Universitaire de N?mes - H?pital Universitaire Carémeau, N?mes, Gard, 30029, France|H?pitaux Universitaires Paris Sud - H?pital Bicêtre, Le Kremlin-Bicêtre, Paris, 94270, France|Hospices Civils de Lyon - H?pital Femme Mère Enfant, Bron, Rh?ne-Alpes, 69500, France|Centre Hospitalier Universitaire de Poitiers, Poitiers, Vienne, 86021, France|H?pital Universitaire Necker Enfants Malades, Paris, 75015, France|Universit?tsklinikum Heidelberg, Heidelberg, Baden-Württemberg, 69115, Germany|Universitaetsklinikum Tuebingen, Tuebingen, Baden-Württemberg, 72076, Germany|Asklepios Klinik Sankt Augustin, Sankt Augustin, Nordrhein-Westfalen, 53757, Germany|Helios Klinikum Berlin-Buch, Berlin, 13125, Germany|Charité Campus Virchow-Klinikum, Berlin, 13353, Germany|Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari, Hamburg, 22081, Germany|Sir Ganga Ram Hospital, New Delhi, Delhi, 110060, India|Sri Ramachandra MedicaL College & Research Institute, Chennai, Tamil Nadu, 600116, India|Christian Medical College Vellore, Vellore, Tamil Nadu, 632004, India|Meir Medical Center, Kfar Saba, HaMerkaz, 4428164, Israel|Schneider Children's Medical Center, Petah Tikva, HaMerkaz, 49202, Israel|Sheba Medical Center, Ramat Gan, HaMerkaz, 5262100, Israel|Rambam Health Care Campus, Haifa, ?eifā, 3109601, Israel|University of Naples Federico II, Napoli, Campania, 80131, Italy|IRCCS Istituto Giannina Gaslini, Genova, Liguria, 16147, Italy|Centro Specialistico Ortopedico Traumatologico Gaetano Pini - CTO, Milano, Lombardia, 20122, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Lombardia, 20122, Italy|Azienda di Rilievo Nazionale e Alta Specializzazione Civico Di Cristina Benfratelli, Palermo, Sicilia, 90127, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, 25123, Italy|Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti, Chieti, 66100, Italy|Ospedale Infantile Burlo Garofolo, Trieste, 34137, Italy|Kanazawa University Hospital, Kanazawa, Ishikawa, 920-8641, Japan|Kanagawa Children's Medical Center, Yokohama, Kanagawa, 232-8555, Japan|Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan|Miyagi Children's Hospital, Sendai, Miyagi, 989-3126, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, 569-8686, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, 330 8777, Japan|Institute of Science Tokyo Hospital, Bunkyō, Tokyo, 113-8519, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, 162-8666, Japan|Chiba Children's Hospital, Chiba, 266-0007, Japan|Kagoshima University Hospital, Kagoshima, 890-8520, Japan|Niigata University Medical & Dental Hospital, Niigata, 951-8520, Japan|St. Luke's International Hospital, Tokyo, 104-8560, Japan|Clinstile, S.A. de C.V., Mexico, Distrito Federal, 6700, Mexico|Crea de Guadalajara, Guadalajara, Jalisco, 44600, Mexico|Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo León, 66460, Mexico|Investigacion y Biomedicina de Chihuahua, Chihuahua, 31000, Mexico|Instituto de Investigaciones Clínicas para la Salud, Durango, 34000, Mexico|Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji, Warsaw, Mazowieckie, 02-637, Poland|Wojewódzki Specjalistyczny Szpital Dzieci?cy im. ?w. Ludwika w Krakowie, Krakow, Ma?opolskie, 31-503, Poland|Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, ?ód?, ?ódzkie, 91-738, Poland|Federal State Budgetary Scientific Institution Research Institute Rheumatology named after V.A.Nasonova, Moscow, Moskva, 115522, Russian Federation|Scientific Center of Children's Health, Moscow, Moskva, 119991, Russian Federation|Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona [Barcelona], 8950, Spain|Hospital Infantil Universitario Ni?o Jesús, Madrid, Madrid, Comunidad De, 28009, Spain|Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Virgen Del Rocio, Sevilla, 41013, Spain|Hospital Universitari i Politecnic La Fe, València, 46026, Spain|Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, 34098, Turkey|9 Eylul University Hospital, Izmir, 35340, Turkey|Bristol Royal Hospital for Children, Bristol, Bristol, City Of, BS2 8BJ, United Kingdom|Alder Hey Children's Hospital, Liverpool, England, L14 5AB, United Kingdom|University College Hospital - London, London, Greater London, NW1 2BU, United Kingdom|Great Ormond Street Hospital For Children NHS Foundation Trust, London, London, City Of, WC1N 3JH, United Kingdom|Oxford University Hospitals - Nuffield Orthopaedic Centre, Oxford, Oxfordshire, OX3 7LD, United Kingdom|Sheffield Children's Hospital, Sheffield, S10 2TH, United Kingdom Less << |
NCT03559270 | Atopic Dermatitis | PHASE3 | TERMINATED | 2022-06-13 | University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Keck School of Medicine University of Southern California, Los Angeles, California, 90033, United States|Wallace Medical Group, Inc., Los Angeles, California, 90056, United States|University of California Davis-Dermatology, Sacramento, California, 95816, United States|Medical Center For Clinical Research, San Diego, California, 92108, United States|University Clinical Trials, Inc., San Diego, California, 92123, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Care Access Research-Walnut Creek, Walnut Creek, California, 94598, United States|GWU/Medical Faculty Associates, Washington, District of Columbia, 20037, United States|Solutions Through Advanced Research, Inc., Jacksonville, Florida, 32256, United States|Olympian Clinical Research, Largo, Florida, 33770, United States|Miami Dermatology and Laser Research, Miami, Florida, 33173, United States|Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines, Florida, 33028, United States|University of South Florida, Tampa, Florida, 33612, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Dermatologic Surgery Specialists, PC, Macon, Georgia, 31217, United States|Advanced Medical Research, Sandy Springs, Georgia, 30328, United States|Advanced Clinical Research LLC, Meridian, Idaho, 83642, United States|Northwestern University, Chicago, Illinois, 60611, United States|University Dermatology, Darien, Illinois, 60561, United States|Arlington Dermatology, Rolling Meadows, Illinois, 60008, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States|The South Bend Clinic Center for Research, South Bend, Indiana, 46617, United States|Forefront Research, Louisville, Kentucky, 40241, United States|Dermatology and Skin Cancer Specialists, Rockville, Maryland, 20850, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Central Dermatology PC, Saint Louis, Missouri, 63117, United States|Skin Specialists, P.C, Omaha, Nebraska, 68144, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, 10003, United States|DermResearchCenter of New York, Inc, Stony Brook, New York, 11790, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Wright State Univ School of Medicine, Fairborn, Ohio, 45324, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|OHSU Center for Health and Healing, Portland, Oregon, 97239, United States|The Pennsylvania Centre for Dermatology, LLC, Exton, Pennsylvania, 19341, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Bellaire Dermatology, Bellaire, Texas, 77401, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|University of Utah MidValley Dematology, Murray, Utah, 84107, United States|MultiCare Good Samaritan Hospital, Tacoma, Washington, 98405, United States|Kirk Barber Research, Calgary, Alberta, T2G 1B1, Canada|Beacon Dermatology, Calgary, Alberta, T3E 0B2, Canada|Alberta DermaSurgery Centre, Edmonton, Alberta, T6G 1C3, Canada|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Simcoderm Medical & Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc., Markham, Ontario, L3P1X2, Canada|Allergy Research Canada Inc., Niagara Falls, Ontario, L2H 1H5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|York Dermatology Center, Richmond Hill, Ontario, L4C 9M7, Canada|Medicor Research Inc, Sudbury, Ontario, P3A 1W8, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|XLR8 Medical Research, Windsor, Ontario, N8W 1E6, Canada|Innovaderm Research Inc, Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique de Quebec Metropolitain, Quebec, G1V 4X7, Canada|Dr. Samuel Sanchez PSC, Caguas, 00727, Puerto Rico|Office of Dr. Alma M. Cruz, Carolina, 00985, Puerto Rico|Ponce School of Medicine CAIMED Center, Ponce, 00716, Puerto Rico|GCM Medical Group, PSC - Hato Rey Site, San Juan, 00917, Puerto Rico Less << |
NCT02340104 | - | Completed | - | - | |
NCT04131738 | Graft-versus-host-disease|Graf... More >>t Vs Host Disease Less << | PHASE1 | COMPLETED | 2022-08-17 | Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States Less << |
NCT05189106 | Amyotrophic Lateral Sclerosis|... More >>Alzheimer Disease|Mild Cognitive Impairment Less << | PHASE1|PHASE2 | ACTIVE_NOT_RECRUITING | 2025-06-01 | Massachusetts General Hospital... More >> - ALS Site, Boston, Massachusetts, 02129, United States|Massachusetts General Hospital - AD Site, Charlestown, Massachusetts, 02129, United States Less << |
NCT04320277 | Pharmacological Action | PHASE2|PHASE3 | UNKNOWN | 2020-07-30 | Fabrizio Cantini, Prato, Tusca... More >>ny, 59100, Italy Less << |
NCT05361109 | Dermatomyositis | PHASE2 | WITHDRAWN | 2023-03-31 | University of Washington Medic... More >>al Center, Seattle, Washington, 98195, United States Less << |
NCT06490757 | Inflammatory Hepatocellular Ad... More >>enoma Less << | PHASE2 | NOT_YET_RECRUITING | 2028-09-02 | - |
NCT05852171 | Mastitis Chronic|Idiopathic Gr... More >>anulomatous Mastitis Less << | PHASE2 | RECRUITING | 2025-10-31 | The First Affiliated Hospital,... More >> Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Less << |
NCT05446831 | ITP|Immune Thrombocytopenia | PHASE2 | UNKNOWN | 2023-12-01 | Peking University Insititute o... More >>f Hematology, Peking University People's Hospital, Beijing, Beijing, 100010, China Less << |
NCT06797310 | Alopecia Areata | PHASE2 | NOT_YET_RECRUITING | 2026-12-31 | National Taiwan University Hos... More >>pital, Taipei, 100, Taiwan Less << |
NCT04517253 | Nakajo-Nishimura Syndrome|Chro... More >>nic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome|STING-Associated Vasculopathy With Onset in Infancy|Aicardi Goutieres Syndrome Less << | PHASE2|PHASE3 | ACTIVE_NOT_RECRUITING | 2025-11-24 | Nara Medical University Hospit... More >>al, Kashihara, Nara, 634-0813, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, 113-8519, Japan|National Center For Child Health And Development, Setagaya-ku, Tokyo, 157-8535, Japan|Hiroshima University Hospital, Hiroshima, 734-8551, Japan|Wakayama Medical University Hospital, Wakayama, 641-0012, Japan Less << |
NCT04399798 | Corona Virus Infection | PHASE2 | UNKNOWN | 2020-11-15 | - |
NCT05950542 | Vitiligo, Generalized | NOT_YET_RECRUITING | 2024-12-30 | - | |
NCT04340232 | COVID-19 | PHASE2|PHASE3 | WITHDRAWN | 2025-10-21 | University of Colorado, Denver... More >>, Aurora, Colorado, 80045, United States Less << |
NCT04901325 | Pyoderma Gangrenosum|Skin Dise... More >>ases|Wound Heal|Pyoderma|Skin Ulcer Less << | PHASE2 | RECRUITING | 2025-05-31 | Oregon Health and Science Univ... More >>ersity, Portland, Oregon, 97239, United States Less << |
NCT06475820 | Acute Lymphoblastic Leukemia|A... More >>cute Myeloid Leukemia|Biphenotypic Acute Leukemia|Malignant Lymphoma|Myelodysplastic Syndromes Less << | PHASE2|PHASE3 | ACTIVE_NOT_RECRUITING | 2027-04-01 | Dmitry Rogachev National Medic... More >>al Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Samory-Mashela,1, 11198, Russian Federation Less << |
NCT06548802 | Pulmonary Injury After Intrace... More >>rebral Hemorrhage Less << | PHASE1|PHASE2 | RECRUITING | 2025-06-26 | Tianjin Medical University Gen... More >>eral Hospital, Tianjin, Tianjin, 300052, China Less << |
NCT03921554 | Aicardi Goutieres Syndrome | PHASE2 | COMPLETED | 2024-03-25 | Children's Hospital of Philade... More >>lphia, Philadelphia, Pennsylvania, 19104, United States Less << |
NCT05074420 | Covid19|Corona Virus Infection | PHASE3 | RECRUITING | 2025-05-26 | Arnold Palmer Hospital for Chi... More >>ldren, Orlando, Florida, 32806, United States|Children's Hospital of Michigan, Detroit, Michigan, 48201, United States|The University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|University of Texas Medical Branch, Galveston, Texas, 77555, United States|University of Virginia Health System, Charlottesville, Virginia, 22908, United States|MultiCare Health System, Tacoma, Washington, 98405, United States|Centre Hospitalier Régional de la Citadelle, Liège, 4000, Belgium|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90410000, Brazil|Centro de Pesquisa Sao Lucas, Campinas, S?o Paulo, 13034-685, Brazil|Instituto de Pesquisa clinica de Campinas, Campinas, S?o Paulo, 13060-080, Brazil|CECIP - Centro de Estudos do Interior Paulista, Jau, S?o Paulo, 17201130, Brazil|Pesquisare Saude, Santo André, S?o Paulo, 09080-110, Brazil|Instituto Nacional de Pediatria, Mexico City, Distrito Federal, 04530, Mexico|Hospital Infantil de Mexico Federico Gomez, Mexico City, 06720, Mexico|Hospital Universitario de Araba (HUA)- Hospital Txagorritxu, Vitoria-Gasteiz, Araba, 01009, Spain|Hospital Universitario La Paz, Madrid, Madrid, Comunidad De, 28046, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, 31009, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain Less << |
NCT05792462 | NMO Spectrum Disorder | PHASE1|PHASE2 | RECRUITING | 2025-12-30 | Tianjin Medical University Gen... More >>eral Hospital, Tianjin, Tianjin, 300052, China Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.46mL 2.69mL 1.35mL |
26.92mL 5.38mL 2.69mL |